To include your compound in the COVID-19 Resource Center, submit it here.

ReN1869: Began Phase II testing

ReNeuron Ltd. (LSE:REN), London, U.K.
Product: ReN1869

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE